On this interview, we converse to Holger Eickhoff, CEO and Founding father of Scienion, about their newest know-how, The Nucleus Automation Ecosystem, and the way it will deliver new flexibility to the manufacturing market in life sciences.
Please are you able to introduce your self and inform us about your function at Scienion?
My identify is Holger Eickhoff, and I’m the Founder and CEO of Scienion. I’ve had the identical job description for the final 22 years.
Scienion is a world chief in shelling out precision, utilizing your merchandise to speed up the life sciences by offering accessible options combining each biology and know-how. Are you able to inform us extra about Scienion and your core goals and values?
Science is basically two phrases merged into one; science and imaginative and prescient. That is how we got here up with the corporate identify.
Our clients are our fundamental precedence, as we dispense and assay improvement options to permit for precision drugs, a serious private well being improvement.
Are you able to inform us what the time period ‘precision shelling out’ means and what sectors it advantages within the life sciences?
Precision shelling out refers to reproducibility, making certain precision within the screening and medical testing fields. The extra exact we are able to dispense reagents, the extra exact the analysis. From this, we are able to sense, for instance, if folks have an autoimmune dysfunction or an allergy with excessive specificity.
Picture Credit score: maxuser/Shutterstock.com
Presently, you will have a wide range of providers and merchandise accessible for purchasers that encompasses automation, multiplex evaluation, and miniaturization. Are you able to inform us extra about a few of your core merchandise and the way they can profit all facets of life sciences analysis from its preliminary phases all through to excessive throughput manufacturing?
We accompany our clients from the early phases of product improvement by to manufacturing. Basically, if the product makes it to market, we offer applied sciences that facilitate the manufacturing of as many merchandise as required. All through the pandemic, we carried out varied checks, and the lateral move take a look at strips and PCR checks which are so acquainted at the moment are all primarily based on our know-how.
We are able to both promote our buyer’s tools to assist within the manufacturing of tens of millions of checks or contract producers which have the capability to check in-house. We’re virtually a one cease store for all times science options.
Furthermore, we’re attentive to our buyer’s wants; we do not simply promote the tools. For example, if our buyer needs us to conduct checks for them, we are able to completely accommodate this and switch the outcomes to them later down the road. In different phrases, we offer options to our buyer’s issues, no matter what scientific problem must be addressed. In a quickly advancing market, we discover that is the most effective technique.
Scienion has just lately launched its newest product, The Nucleus Automation Ecosystem, a completely built-in platform bringing new flexibility to the manufacturing market. Are you able to inform us extra about this platform and the way it works?
The Nucleus Automation Ecosystem is a completely built-in platform that provides developments in modularity, scalability, and suppleness.
If we have been to check the Nucleus to an iPhone, the Nucleus Automation Ecosystem can be much like an app. We are able to additionally provide a MacBook Professional if the person needs to upscale this.
The system has base modules the place you may perform a course of, validate it, after which scale it to any scale. It suits our present philosophy very effectively. We’re at the moment working with new industry-leading elements and have acquired excellent suggestions on the idea up to now.
Science – SLAS 2023Play
Scienion – SLAS 2023 from AZoNetwork on Vimeo.
With varied new automated tools changing into accessible within the life sciences, what makes your product distinctive?
Having the ability to validate an entire course of in a single module after which scale to any scale primarily based on the shopper’s wants makes our providing so distinctive, and this goes past any of the distributed options we at the moment present.
It’s a mixture of shelling out substrate dealing with, gluing, welding, and so on., versus getting an entire diagnostic take a look at equipment or a pharmaceutical system manufactured after which having to scale it additional down the road.
The Nucleus Platform additionally reduces the carbon footprint of processes attributable to them being housed in the identical enclosure. Why was it essential to design a product that was not solely exact however environmentally pleasant too?
Providing a ‘clear,’ environmentally pleasant product is essential as we would like to have the ability to market this product worldwide. At current, it’s onerous to discover a clear room that may produce correct diagnostic checks in each a part of the world.
Moreover, the method steps are housed throughout the similar enclosure, lowering the system’s general footprint. It is usually absolutely autonomous with its personal clear room, together with humidification, air-con, and so on. This enables for important price financial savings because the person doesn’t require an exterior giant clear room with further utility beds. It is a nice benefit for our clients.
The decreased footprint can be an enormous benefit for researchers as worktop house is in excessive demand. Researchers are at the moment conducting groundbreaking analysis inside a tiny house, and we hope this modular system shall be a superb resolution to this, permitting R&D to be carried out multi functional place. Then, if it must be scaled up, this may be performed in a corridor reasonably than in a clear room, which is far more environmentally pleasant.
How will The Nucleus proceed to help your present clients in addition to present new alternatives in fields resembling medical gadgets?
Our current buyer base loves the brand new platform, because it signifies that we are able to hold including processes that aren’t at the moment a part of our providing, and we’re doing this with industry-standard automation techniques.
For the medical system {industry}, this providing is extra of a completed product than only a section of it, and that is very a lot appreciated throughout the discipline.
Picture Credit score: sfam_photo/Shutterstock.com
You might be at the moment showcasing the primary prototype of the platform at SLAS 2023, permitting folks to see and watch dwell demonstrations. How essential is that this in your clients, and what worth do worldwide exhibitions like SLAS have when launching new merchandise?
Having the ability to showcase the platform prototype at exhibitions resembling SLAS means materializing an idea now we have spoken about. This helps to construct a way of belief all through the {industry}, as folks can come over, see the product, really feel it, and, most significantly, take a look at it.
That is additionally an incredible alternative for people to be taught extra about our new providing and ask any questions they could have, talking first-hand to the consultants who know the product inside and outside.
Sometimes, sturdy consumer relationships take years to develop; there is no such thing as a shortcut. Working with the precise accomplice is essential; chatting with firm representatives at exhibitions like SLAS is a key start line on this journey.
Regardless of the issue of transporting it from Europe, we’re very proud to have the ability to showcase our prototype at SLAS.
At Scienion, you might be additionally strongly dedicated to R&D, collaborating in each inner analysis efforts in addition to taking part in varied nationwide and worldwide analysis tasks. Why is that this, and the way essential is collaboration to those tasks?
Scienion is a really collaborative firm, and it’s so essential that we’re in a position to collaborate with our clients.
Inside R&D, we sponsor and collaborate with world-leading analysis organizations. We contemplate ourselves part of cutting-edge science. We don’t need to present solely a instrument but additionally the data behind it. Collaboration is essential to Scienion’s future success, as what we see within the lab at the moment will doubtlessly grow to be accessible in the marketplace within the subsequent six to eight years.
Picture Credit score: Pressmaster/Shutterstock.com
Are you hopeful that with continued technological developments, we’ll proceed to see improved diagnostic and bioanalysis take a look at platforms? What would this imply for sufferers, customers, and public well being worldwide?
When folks go to the medical doctors, they face the ‘Stone Age’ know-how that’s nonetheless in use. That is what motivates us to hold out the work that we do at Scienion. For example, think about a know-how that is ready to present single-cell decision in oncology, with the potential to make sure a affected person with a tumor leaves the hospital with zero oncologic cells.
We’ll hold working onerous till these ideas materialize and this know-how is carried out.
It might even be revolutionary to democratize outcomes, making them extra comprehensible for an on a regular basis particular person who lacks specialised medical data. This shall be a giant collaborative effort between medical doctors and clinics, however that is one thing that we’re in the course of engaged on.
What’s subsequent for Scienion? Are you concerned in any thrilling upcoming tasks?
The longer term is unclear by way of upcoming tasks. Ideally, we need to observe the traits.
One development that we’re seeing is that our developments and merchandise meant for all times science and diagnostics will grow to be life-style merchandise, resembling sensors in watches and wristbands. We see enterprise shifting on this route and coming into the mainstream. We now have entertained such purposes during the last 5 to 6 years, and we see this changing into a mega-trend within the close to future.
